LifeSciences BC > News > Industry News > 2014 > Biotechnology Focus Magazine – Cardiome to distribute BRINAVESS in Spain

Print Friendly

B.C. Industry News

Biotechnology Focus Magazine – Cardiome to distribute BRINAVESS in Spain

March 28, 2014

BIOTECHNOLOGY FOCUS

Cardiome Pharma Corp. has entered into a distribution agreement with Logista Pharma S.A., headquartered in Madrid, Spain, to distribute BRINAVESSâ„¢ (vernakalant IV) within the Spanish market.

BRINAVESS pricing has already been approved nationally by La Comisión Interministerial de Precios de los Medicamentos, Spain’s official medical drug pricing and reimbursement agency, a significant step towards gaining market acceptance.  Cardiome believes the state-of-the-art processes developed by Logista Pharma will ensure that BRINAVESS orders to all its hospital customers will be met on time.

Additionally the company has also entered into an agreement with VIANEX, S.A., headquartered in Erythrea, Greece, for the commercialization and distribution of BRINAVESSâ„¢ (vernakalant IV) in Greece.

Financial details of both agreements were not disclosed.